Skip to content
Our Company
Overview
Team
Collaborators
In Memoriam
Technology
Overview
The Vaccine Platform
Viral Hemorrhagic Fever Vaccines Pipeline
Emerging & Re-emerging Disease Vaccines
Medical Counter Measures
Proteins & Adjuvants
Newsroom
Contact
Cookie Policy
Privacy Policy
Terms of Use
Hawaii Biotech Completes Dosing of Phase 1 Trial for Dengue Virus Monovalent Vaccine
Post navigation
Previous:
Hawaii Biotech Initiates Phase 1 Clinical Trial for Dengue Vaccine
Next:
Advanced Bioscience Laboratories to Manufacture Hawaii Biotech’s Dengue Vaccine for Clinical Trial
